Mayne Pharma Group Limited (ASX:MYX)
3.210
-0.070 (-2.13%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is July - June.
Year Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Dermatology | 174.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dermatology Growth | 206.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Womens Health | 142.83M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Womens Health Growth | 130.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 70.71M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 9.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Metrics Contract Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Metrics Contract Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is July - June.
Year Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| United States | 322.13M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 158.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia and New Zealand | 40.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia and New Zealand Growth | -2.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | 13.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth | 34.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe and Other | 7.13M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe and Other Growth | 98.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 5.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 23.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|